• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Current meta-analysis does not support the possibility of COVID-19 reinfections

tetano

Editor, Senior Moderator
J Med Virol


. 2020 Sep 8.
doi: 10.1002/jmv.26496. Online ahead of print.
Current meta-analysis does not support the possibility of COVID-19 reinfections


M Arafkas[SUP] 1 [/SUP], T Khosrawipour[SUP] 2 3 [/SUP], P Kocbach[SUP] 4 [/SUP], K Zielinski[SUP] 5 [/SUP], J Schubert[SUP] 6 [/SUP], A Mikolajczyk[SUP] 7 [/SUP], M Celinska[SUP] 7 [/SUP], V Khosrawipour[SUP] 2 [/SUP]



Affiliations

Abstract

Background: COVID-19 reinfections could be a major aggravating factor in this current pandemic, as this would further complicate potential vaccine development and help to maintain worldwide virus pockets. To investigate this critical question, we conducted a clinical meta-analysis including all available currently reported cases of potential COVID-19 reinfections.
Methods: We searched for all peer-reviewed articles in the search engine of the National Center for Biotechnology Information. While there are over 30.000 publications on COVID-19, only about 15 specifically target the subject of COVID-19 reinfections. Available patient data in these reports was analyzed for age, gender, time of reported relapse after initial infection and persistent COVID-19 positive PCR results.
Results: Following the first episode of infection, cases of clinical relapse are reported at 34 (mean) ? 10,5 days after full recovery. Patients with clinical relapse have persisting positive COVID-19 PCR testing results until 39 ? 9 days following initial positive testing. For patients without clinical relapse, positive testing was reported up to 54 ? 24 days. There were no reports of any clinical reinfections after a 70-day period following initial infection.
Conclusions: Reports of COVID-19 reinfections all appear within a vulnerable timeframe, where affected patients are still tested positive for COVID-19 via PCR. According to our data, it is most likely that all reported cases of COVID-19 reinfections are in fact protracted initial infections. To diagnose a true COVID-19 reinfection, positive COVID-19 testing combined with recurrent clinical symptoms occurring outside of this timeframe is required. This article is protected by copyright. All rights reserved.

Keywords: COVID-19; coronavirus; effective; measures; pandemic; spread.
 
Back
Top Bottom